Antonella d’Arminio Monforte

Author

Also Known As

A Cozzi-Lepri, A D'Arminio Monforte, A De Luca, A D’Arminio Monforte, A MONFORTE, A Monforte, A d'Arminio Monforte, A d’Arminio Monforte, A. D'Arminio Monforte, A. D. Monforte

957

Publications

46.9K

Citations

104

H-Index

230

Concepts

All Affiliations

University of Milan University College London Ospedale San Paolo Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani Luigi Sacco Hospital

About

Antonella d’Arminio Monforte is an author at University of Milan specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	95	8.4K
2	Health Sciences	5	5	1.2K
3	Natural Sciences	3	3	197
4	Arts	1	1	13
5	Engineering	1	1	76

Antonella d’Arminio Monforte

379

Publications

35.7K

Citations

H-Index

Page 1

	Year	Citations
Compassionate Use of Remdesivir for Patients with Severe Covid-19 Jonathan Grein, Norio Ohmagari, Daniel D. Shin, New England Journal of Medicine	2020	2.9K
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies Matthias Egger, Margaret May, Geneviève Chêne, The Lancet Hiv-1-infected PatientsTreatment And PreventionHuman RetrovirusClinical EpidemiologyActive Antiretroviral Therapy	2002	1.5K
Changing patterns of mortality across Europe in patients infected with HIV-1 Amanda Mocroft, Stefano Vella, Antonio Chiesi, The Lancet Sexual HealthEpidemiological TrendEpidemiological OutcomeTreatment And PreventionClinical Epidemiology	1998	1.3K
Decline in the AIDS and death rates in the EuroSIDA study: an observational study Amanda Mocroft, Bruno Ledergerber, Christine Katlama, The Lancet Sexual HealthEpidemiological TrendDeath RatesEpidemiological OutcomeEurosida Study	2003	1.2K
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies Adam Trickey, Margaret May, Jörg Janne Vehreschild, The Lancet HIV	2017	1.1K
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study Nina Friis‐Møller, Rainer Weber, Peter Reiss, AIDS Cardiometabolic RiskDad StudyClinical EpidemiologyPublic HealthDyslipidemia	2003	982
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration Colette Smith, Lene Ryom, Rainer Weber, The Lancet Sexual HealthEpidemiological TrendEpidemiological OutcomeUnderlying CausesTreatment And Prevention	2014	913
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study Signe Westring Worm, Caroline Sabin, Rainer Weber, The Journal of Infectious Diseases	2009	642
Female gender is associated with long COVID syndrome: a prospective cohort study Francesca Bai, Daniele Tomasoni, Camilla Falcinella, Clinical Microbiology and Infection Female GenderSexual HealthLong CovidGender StudiesCovid-19 Pandemic	2021	635
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients Antonella d’Arminio Monforte, Alessandro Cozzi‐Lepri, Giovanni Rezza, AIDS	2000	556

Page 1